Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1008402-47-8
1644231-07-1
2128735-22-6
2182602-20-4
2182602-22-6
677000-36-1
2183440-69-7 | Sulfo-Cy5.5 carboxylic acid | AA019EGS | MFCD31580082
1259278-12-0 | Benzyl ((1S,3R)-3-aminocyclohexyl)carbamate | AA019EK2 | MFCD28902159
244268-36-8 | 4-Methyl-5-(trifluoromethyl)pyridazin-3(2H)-one | AA019EMX | MFCD30546013
1704064-24-3 | (2-Fluoro-4-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid | AA019EQ5 | MFCD28805544
13241-36-6 | (3aS,6aS)-dihydrofuro[3,2-b]furan-3,6(2H,5H)-dione | AA019ETG | MFCD31560358
1800015-70-6 | cis-5-Bromo-3-(3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)-2,3-dihydrobenzofuran | AA019EWW | MFCD29059411
42749-52-0 | (2-Nitrobenzyl)glycine | AA019EZL | MFCD11138974
76241-80-0 | 3-Bromophthalonitrile | AA019FUR | MFCD19689407
1396967-48-8 | 3-methyl-2-[(3-methylphenyl)formamido]butanoic acid | AA019GFE | MFCD03658009
380569-12-0 | 4-[(5Z)-5-[(4-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid | AA019GND | MFCD02989165